To mark Rare Disease Day we recently spoke with Jonathan Wadsley (Weston Park Hospital, Sheffield, UK) about recent advancements in care for medullary thyroid cancer.
Browsing: thyroid cancer
This special report collates data on the epidemiology of thyroid cancer care among adolescents and young adults and proposes a research agenda to improve their care.
Leading experts devise new guidelines to score thyroid nodules and avoid unnecessary surgery and aspiration numbers for benign nodules.
The largest-known study in thyroid cancer patients highlights that skeletal complications in high-risk follicular and medullary thyroid cancer patients are an indicator of poor prognosis.
In this review article from the International Journal of Endocrine Oncology, the authors explore the altered molecular pathways implicated in the development of medullary thyroid cancer and therapeutic strategies based on targeting identified signaling pathways.
In this article from Future Oncology the authors review the current therapeutic options for papillary thyroid carcinoma and explore future targeted therapies.
Given that treatment goals following surgery for medullary thyroid carcinoma differ depending on tumor stage and other the parameters of progressive disease, how might follow-up treatment be risk stratified?
Medullary thyroid carcinomas commonly spread to cervical and mediastinal lymph nodes – learn further about the surgical management of lymph node metastases in the disease in this review article.
Lenvatinib found to be associated with clinically significant progression-free survival in advanced thyroid cancer across most common metastatic sites.
“Our goal as clinicians should be to offer these generally low-risk patients a management strategy with the least morbidity, fewest complications, best long-term cancer control and quality of life.”